Rocket Lab ($RKLB) Q2 2026 Earnings Analysis — Revenue Beats Estimates, Sets Records, but After-Hours Trading Slips on Continued Losses
Earnings Scorecard
Revenue: $234 million (+62% YoY, estimate $231 million) ✅ Beat
EPS: GAAP net loss per share $0.08 (adjusted estimate -$0.05; different bases prevent direct comparison)
Guidance: Newly issued — Q3 2026 revenue $250–$265 million, adjusted EBITDA loss $17–$23 million
Stock reaction: After-hours -1.36% ($78.95) — as of 06:00 KST, 08-11
The Positives
Record revenue: Q2 revenue of $234 million, up 62% year-over-year
Backlog surge: $2.36 billion, up 137% year-over-year
Narrower losses: Adjusted EBITDA loss of $8.83 million (vs. $27.58 million in the prior-year period)
Demand rebounded across both launch services and space systems, pushing quarterly revenue to a fresh high. The combination of major contract wins — including with the U.S. Space Force — and acquisition announcements further thickens the long-term growth narrative.
The Negatives
Persistent net loss: Net loss attributable to common stockholders of approximately $49.3 million (Q2 2026)
Q3 profit-and-loss burden: Adjusted EBITDA loss guidance is wider than Q2 results
Rising operating costs: R&D plus SG&A combined at roughly $142 million, reflecting a high-cost structure
Growth is rapid, but the company has not yet reached the profitability stage. Ongoing mid-size rocket development and integration costs from acquisitions could limit the near-term pace of margin improvement.
What Management Said
Management attributed the record quarter to surging demand across all business segments. The completion of the Mynaric and Motive acquisitions, along with the announced Iridium deal, underscored the company's push to evolve into a vertically integrated space company spanning in-house launch to satellite operations.
Market Reaction and What to Watch Next
Despite the revenue beat and strong backlog, persistent losses and a heavier Q3 profit-and-loss outlook appear to have triggered selling pressure in after-hours trading.
Where Q3 revenue lands within the guidance range ($250–$265 million) is the key checkpoint.
Watch whether the company meets its Neutron first-flight delivery target (Q4 2026) on schedule.
Monitor the progress of the Iridium acquisition and the impact of integration costs and share dilution on earnings.
면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.